News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ophthotech Corporation (OPHT) Announces Closing Of Registered Public Offering Of Common Stock Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares


2/19/2014 9:07:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (NASDAQ:OPHT) announced today the closing of its previously announced registered public offering of 2,628,571 shares of its common stock at a price to the public of $31.50 per share, before underwriting discounts. Of the shares sold in the offering, 1,900,000 were sold by Ophthotech and 728,571 were sold by certain stockholders of the company. 342,857 of the shares sold by selling stockholders were sold as a result of the full exercise by the underwriters of a 30-day option to purchase these additional shares at the public offering price, less underwriting discounts.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES